Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Driver rams into pedestrians in western France, several injured
Zohran Mamdani wins NYC mayoral race, capping meteoric rise
Kalmaegi death toll climbs to 66 as Philippine survivors confront destruction
China's Shenzhou-20 return mission delayed due to space debris impact
At least 7 dead after UPS plane crashes in Kentucky, erupts into ball of fire
